BOSTON--(EON: Enhanced Online News)--AdvaStim, Inc., www.advastim.com, a leading developer of ASIC-based technology platforms for neuromodulation therapies, announced today that George Cintra has joined the company as Strategic Advisor for Technology and Business Development. Mr. Cintra has more than 25 years of experience leading product development, engineering and business development functions in the medical device and consumer products industries.
“Having someone of George’s extensive industry background join our team demonstrates the exciting commercial potential that our technology promises to the neuromodulation device field”
“Having someone of George’s extensive industry background join our team demonstrates the exciting commercial potential that our technology promises to the neuromodulation device field,” said Laurence Derose, CEO and Co-founder of AdvaStim. “Our ASIC-based platform can potentially open new avenues and approaches for targeted neurostimulation therapies, and George’s extensive industry contacts and long experience in the field can help us best leverage these opportunities.”
“AdvaStim’s ASIC-based technology represents a breakthrough for neuromodulation therapeutic systems to expand into a variety of clinical indications,” said George Cintra. “I’m excited to join AdvaStim and help further this technology for the next generation of neuromodulation therapy options.”
Mr. Cintra was the Executive Vice President and Chief Technology Officer at Integer Holdings, Inc. (formerly Greatbatch Medical), a global leader in the design and development of implantable medical devices, from 2013 through January 2016, and served in an advisory capacity through January 2017. In addition to leading research, development, engineering and regulatory & clinical affairs, he also led the QiG Group and CCC Medical Devices subsidiaries for the company. Prior to Integer, he had a 16-year career holding technology and product development positions at P&G, Gillette, and Duracell. He has been awarded 39 U.S. and foreign patents across a broad range of power systems and electromechanical products. Mr. Cintra earned his B.S. in chemical engineering and completed graduate studies at Carnegie Mellon and the University of Virginia.
About AdvaStim, Inc.
AdvaStim is a technology developer addressing the multi-billion dollar neurostimulation market with a disruptive hardware/software technology platform to help emerging device companies effectively implement the next generation of implantable device therapeutics. For more information, visit http://www.advastim.com